60 Degrees Pharmaceuticals Reports 164% Year-Over-Year Increase in Q3 2024 Sales Revenue
60 Degrees Pharmaceuticals reported Q3 2024 revenue of $135,000, a 164% increase, with improved gross profit and rising expenses.Quiver AI Summary60 Degrees Pharmaceuticals, Inc. reported a significant...
WallachBeth Capital Announce Closing Of 60 Degrees Pharmaceuticals IPO At $5.30 Per Unit
/PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that 60 Degrees...